Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress

Neurobiology of Disease

Volumn 96, Issue , 2016, Pages 54-66

  Papale, Ligia A ^a   Li, Sisi ^a,b   Madrid, Andy ^a,b   Zhang, Qi ^c   Chen, Li ^d   Chopra, Pankaj ^d   Jin, Peng ^d   Keleş, Sündüz ^a   Alisch, Reid S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Hydroxymethylcytosine; Acute stress; DNA methylation; Epigenetics; Gene expression; Sex specific

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; TRANSCRIPTION FACTOR; 5 METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITE; DNA EXTRACTION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HIPPOCAMPUS; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RNA EXTRACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPATIAL MEMORY; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE ONTOLOGY; GENETIC EPIGENESIS; GENETICS; MENTAL STRESS; METABOLISM; METHYLATION; PATHOLOGY; SEX FACTOR;

5-METHYLCYTOSINE; ANIMALS; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; FEMALE; GENE ONTOLOGY; HIPPOCAMPUS; MALE; METHYLATION; MICE; MICE, INBRED C57BL; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84984977855     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.08.014     Document Type: Article

References (102)

1. Abdolmaleky, H.M., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15 (2006), 3132–3145.
2. Al-Mahdawi, S., et al. The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases. Front. Neurosci., 8, 2014, 397.
3. Altemus, M., et al. Sex differences in anxiety and depression clinical perspectives. Front. Neuroendocrinol. 35 (2014), 320–330.
4. Aston, C., et al. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry 10 (2005), 309–322.
5. Bailey, T.L., DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27 (2011), 1653–1659.
6. Bale, T.L., Epigenetic and transgenerational reprogramming of brain development. Nat. Rev. Neurosci. 16 (2015), 332–344.
7. Balint, S., et al. Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition. Psychol. Med. 39 (2009), 1337–1345.
8. Basmanav, F.B., et al. Investigation of the role of TCF4 rare sequence variants in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168B (2015), 354–362.
9. Bradley-Whitman, M.A., Lovell, M.A., Epigenetic changes in the progression of Alzheimer's disease. Mech. Ageing Dev. 134 (2013), 486–495.
10. Butts, T., et al. Transit amplification in the amniote cerebellum evolved via a heterochronic shift in NeuroD1 expression. Development 141 (2014), 2791–2795.
11. Cahill, L., Why sex matters for neuroscience. Nat. Rev. Neurosci. 7 (2006), 477–484.
12. Castilhos, R.M., et al. Huntington disease and Huntington disease-like in a case series from Brazil. Clin. Genet. 86 (2014), 373–377.
13. Chen, C.V., et al. New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice. Horm. Behav. 65 (2014), 211–218.
14. Chen, H.M., et al. Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transl. Psychiatry, 4, 2014, e375.
15. Chiang, M.C., et al. Rosiglitazone activation of PPARgamma-dependent signaling is neuroprotective in mutant huntingtin expressing cells. Exp. Cell Res. 338 (2015), 183–193.
16. Chouliaras, L., et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 34 (2013), 2091–2099.
17. Cirelli, C., et al. Changes in brain gene expression after long-term sleep deprivation. J. Neurochem. 98 (2006), 1632–1645.
18. Collishaw, S., et al. Resilience to adult psychopathology following childhood maltreatment: evidence from a community sample. Child Abuse Negl. 31 (2007), 211–229.
19. Condliffe, D., et al. Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain. Neurobiol. Aging 35 (2014), 1850–1854.
20. Cosgrove, K.P., et al. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol. Psychiatry 62 (2007), 847–855.
21. Fenchel, D., et al. Beyond the HPA-axis: the role of the gonadal steroid hormone receptors in modulating stress-related responses in an animal model of PTSD. Eur. Neuropsychopharmacol. 25 (2015), 944–957.
22. Forero, D.A., et al. A network of synaptic genes associated with schizophrenia and bipolar disorder. Schizophr. Res. 172 (2016), 68–74.
23. Forrest, M.P., et al. Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation. PLoS One, 8, 2013, e73169.
24. Geifman, N., Monsonego, A., Rubin, E., The neural/immune gene ontology: clipping the gene ontology for neurological and immunological systems. BMC Bioinf., 11, 2010, 10.1186/1471-2105-11-458.
25. Geng, Y.G., et al. Comparison of the polymorphisms of androgen receptor gene and estrogen alpha and beta gene between adolescent females with first-onset major depressive disorder and controls. Int. J. Neurosci. 117 (2007), 539–547.
26. Gillberg, C., et al. Brief report: “the autism epidemic”. The registered prevalence of autism in a Swedish urban area. J. Autism Dev. Disord. 36 (2006), 429–435.
27. Goes, F.S., et al. Genome-wide association study of schizophrenia in Ashkenazi Jews. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168 (2015), 649–659.
28. Gonzalez-Mantilla, A.J., et al. A cross-disorder method to identify novel candidate genes for developmental brain disorders. JAMA Psychiatry 73 (2016), 275–283.
29. Grados, M., et al. Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development. Drug Dev. Res. 75 (2014), 372–383.
30. Gray, J.D., et al. Hippocampal gene expression changes underlying stress sensitization and recovery. Mol. Psychiatry 19 (2014), 1171–1178.
31. Gross, J.A., et al. Characterizing 5-hydroxymethylcytosine in human prefrontal cortex at single base resolution. BMC Genomics, 16, 2015, 672.
32. Gurung, R., Prata, D.P., What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review. Psychol. Med. 45 (2015), 2461–2480.
33. Hart, L.S., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J. Clin. Invest. 122 (2012), 4621–4634.
34. Hass, J., et al. Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 59 (2015), 31–39.
35. Hattori, T., et al. DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One, 9, 2014, e88506.
36. Hebert, L.E., et al. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 80 (2013), 1778–1783.
37. Hu, T.M., et al. Resequencing of early growth response 2 (EGR2) gene revealed a recurrent patient-specific mutation in schizophrenia. Psychiatry Res. 228 (2015), 958–960.
38. Hunter, R.G., et al. Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20912–20917.
39. Iossifov, I., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74 (2012), 285–299.
40. Iossifov, I., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515 (2014), 216–221.
41. Johansson, A.S., et al. Altered circadian clock gene expression in patients with schizophrenia. Schizophr. Res. 174 (2016), 17–23.
42. Juhasz, G., et al. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biol. Psychiatry 69 (2011), 762–771.
43. Jukic, M.M., et al. Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder. Neuropsychopharmacology 40 (2015), 839–848.
44. Keyes, K., et al. The role of allelic variation in estrogen receptor genes and major depression in the Nurses Health Study. Soc. Psychiatry Psychiatr. Epidemiol. 50 (2015), 1893–1904.
45. Kim, S.H., et al. Genetic association of the EGR2 gene with bipolar disorder in Korea. Exp. Mol. Med. 44 (2012), 121–129.
46. Kim, K.S., et al. Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism. Brain Res. 1552 (2014), 72–81.
47. Kumar, A., et al. Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes. J. Biol. Chem. 280 (2005), 42619–42626.
48. Kuratomi, G., et al. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 13 (2008), 429–441.
49. Lawrence, M., et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol., 9, 2013, e1003118.
50. Le-Niculescu, H., et al. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009), 155–181.
51. Li, S., et al. Genome-wide alterations in hippocampal 5-hydroxymethylcytosine links plasticity genes to acute stress. Neurobiol. Dis. 86 (2016), 99–108.
52. Liang, Q., et al. Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses. J. Immunol. 186 (2011), 1001–1010.
53. Lisowski, P., et al. Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice. BMC Neurosci., 14, 2013, 144.
54. Love, M.I., et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
55. Maccari, S., et al. Early-life experiences and the development of adult diseases with a focus on mental illness: the human birth theory. Neuroscience, 2016.
56. Malas, S., et al. Sox1-deficient mice suffer from epilepsy associated with abnormal ventral forebrain development and olfactory cortex hyperexcitability. Neuroscience 119 (2003), 421–432.
57. Mamdani, F., et al. Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Transl. Psychiatry, 1, 2011, e13.
58. Marmigere, F., et al. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13 (2003), 646–655.
59. Martin, E.I., et al. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin. Lab. Med. 30 (2010), 865–891.
60. McCarthy, M.M., et al. The epigenetics of sex differences in the brain. J. Neurosci. 29 (2009), 12815–12823.
61. McCarthy, M.M., et al. Sex differences in the brain: the not so inconvenient truth. J. Neurosci. 32 (2012), 2241–2247.
62. McGowan, P.O., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12 (2009), 342–348.
63. Meaney, M.J., Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24 (2001), 1161–1192.
64. Mellen, M., et al. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151 (2012), 1417–1430.
65. Mencarelli, M.A., et al. Private inherited microdeletion/microduplications: implications in clinical practice. Eur. J. Med. Genet. 51 (2008), 409–416.
66. Nestadt, G., et al. Homeobox genes in obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B (2012), 53–60.
67. Nolen-Hoeksema, S., Sex differences in unipolar depression: evidence and theory. Psychol. Bull. 101 (1987), 259–282.
68. O'Donovan, A., et al. Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis. Markers 30 (2011), 123–132.
69. Pamment, J., et al. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21 (2002), 7776–7785.
70. Papale, L.A., et al. Genome-wide disruption of 5-hydroxymethylcytosine in a mouse model of autism. Hum. Mol. Genet. 24 (2015), 7121–7131.
71. Pidsley, R., et al. Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol., 15, 2014, 483.
72. Popoli, M., et al. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 13 (2012), 22–37.
73. Poulter, M.O., et al. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol. Psychiatry 64 (2008), 645–652.
74. Qureshi, I.A., Mehler, M.F., Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 13 (2012), 528–541.
75. Rivolta, D., et al. Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing. J. Neurosci. 34 (2014), 5909–5917.
76. Robertson, K.D., DNA methylation and human disease. Nat. Rev. Genet. 6 (2005), 597–610.
77. Roth, T.L., et al. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 65 (2009), 760–769.
78. Rotheram-Fuller, E., et al. Social involvement of children with autism spectrum disorders in elementary school classrooms. J. Child Psychol. Psychiatry 51 (2010), 1227–1234.
79. Rubin, T.G., et al. Experience and the ever-changing brain: what the transcriptome can reveal. BioEssays 36 (2014), 1072–1081.
80. Rutter, M., et al. Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. J. Child Psychol. Psychiatry 44 (2003), 1092–1115.
81. Schlaudraff, F., et al. Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease. Neurobiol. Aging 35 (2014), 2302–2315.
82. Scobie, K.N., et al. Kruppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis. J. Neurosci. 29 (2009), 9875–9887.
83. Shi, S.Q., et al. Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks. Transl. Psychiatry, 6, 2016, e748.
84. Shiota, M., et al. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Free Radic. Biol. Med. 51 (2011), 1320–1328.
85. Singmann, P., et al. Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics Chromatin, 8, 2015, 43.
86. Song, C.X., et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29 (2011), 68–72.
87. Szulwach, K.E., et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14 (2011), 1607–1616.
88. Tollervey, J.R., Lunyak, V.V., Epigenetics: judge, jury and executioner of stem cell fate. Epigenetics 7 (2012), 823–840.
89. Trabzuni, D., et al. Widespread sex differences in gene expression and splicing in the adult human brain. Nat. Commun., 4, 2013, 2771.
90. Villar-Menendez, I., et al. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neruomol. Med. 15 (2013), 295–309.
91. Wallace, D.L., et al. CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nat. Neurosci. 12 (2009), 200–209.
92. Wang, F., et al. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet. 22 (2013), 3641–3653.
93. Wang, X., et al. The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice. J. Neurosci. 34 (2014), 7253–7265.
94. Weaver, I.C., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 (2004), 847–854.
95. Wei, Y., et al. Association study of three single-nucleotide polymorphisms in the cyclic adenosine monophosphate response element binding 1 gene and major depressive disorder. Exp. Ther. Med. 9 (2015), 2235–2240.
96. Weissman, M.M., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276 (1996), 293–299.
97. Wockner, L.F., et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl. Psychiatry, 4, 2014, e339.
98. Wooten, G.F., et al. Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 75 (2004), 637–639.
99. Yao, B., Jin, P., Cytosine modifications in neurodevelopment and diseases. Cell. Mol. Life Sci. 71 (2014), 405–418.
100. Yu, G., et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 (2012), 284–287.
101. Zhang, T.Y., et al. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology 38 (2013), 111–123.
102. Zhubi, A., et al. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl. Psychiatry, 4, 2014, e349.